Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial.
about
Evaluation of chronic kidney disease in chronic heart failure: From biomarkers to arterial renal resistancesAlbuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fractionImproving prognosis estimation in patients with heart failure and the cardiorenal syndromeThe kidney in heart failure: an update.Acute Kidney Injury in Pediatric Heart FailureThe risk of death associated with proteinuria in heart failure is restricted to patients with an elevated blood urea nitrogen to creatinine ratio.Incorporating common biomarkers into the clinical management of heart failureRenal biomarkers of kidney injury in cardiorenal syndrome.Current and novel renal biomarkers in heart failure.Biomarkers: optimizing treatment guidance in heart failure.Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin.Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases.Novel renal biomarkers to assess cardiorenal syndromeBiomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure.The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction.Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors.Heart failure, post-hospital mortality and renal function in Tanzania: A prospective cohort study.Prevalence, predictors and prognostic significance of microalbuminuria in acute cardiac patients: a single center experience.The effect of continuous infusion loop diuretics in patients with acute decompensated heart failure with hypoalbuminemia.Heart Failure and Kidney Disease.Urine protein biomarkers for detection of cardiovascular disease and their use for the clinic.Effects of tolvaptan on urine output in hospitalized heart failure patients with hypoalbuminemia or proteinuria.Effects of Candesartan on Left Ventricular Function, Aldosterone and BNP in Chronic Heart Failure.Urinary albumin excretion in heart failure with preserved ejection fraction: an interim analysis of the CHART 2 study.Cardiorenal medicine: partners in practice?Clinical outcome of renal tubular damage in chronic heart failure.Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.Heart failure: not a single organ disease but a multisystem syndrome.Serum neutrophil gelatinase-associated lipocalin and cystatin C are diagnostic markers of renal dysfunction in older patients with coronary artery disease.
P2860
Q28084462-3FA09542-1C6B-4977-A15B-2C9028F16C55Q34633271-5F43396C-9396-4BAE-A80A-755CB8B3D748Q35020305-F53474A0-4F44-4602-A917-C992BAACCBEAQ35737499-90A18906-7153-4BC4-BBD8-89A58608075AQ36886257-467EB63F-996E-45CF-8FB6-990D013A10C4Q37179961-460E488B-31CC-4DAE-8874-115004C4A444Q37347009-7E741D78-557F-4FD3-A817-3E47A179D940Q37850384-A2D8F3B3-D4DD-405B-8DD2-93F73BC4668EQ37878418-51D1A671-0FFB-4ED6-9CED-FEC87BEE2678Q37903747-F8493808-DBAE-46E8-9B25-BB7AD80A3E45Q38096829-E90EB16D-62FC-4BAA-8923-A87AACE39764Q38208727-213C96FB-31AF-4ADD-8F71-5FF48C53BE4EQ38252731-0EB9621E-25E1-4F18-8CEB-86D31AF16A17Q38626779-53FAC653-6CAF-4410-9C41-787E8B588D14Q38755320-90EDD028-88A7-48B6-A307-2D8538A7784DQ39127729-3D1F5C16-5BED-4AA0-A079-846C91760020Q39224155-341F4EA6-2EF5-49B2-BA53-3101C457E982Q43925452-1F71D4E4-AB31-4A2E-BB22-6BD8A4EE5A51Q44596266-93E26F40-99C9-431E-9959-4483BAE65843Q45835244-D3126BE4-3204-4956-9770-6987085ACF81Q47437642-61F4A120-5C57-413B-A62E-51A2B3669AB4Q47638470-B536A58B-5BAE-4C53-8975-CF9F21891A49Q47732990-EE2782CF-6D9D-4026-95D4-89627184CF85Q48678090-A2BAD351-B7EC-4B02-A6BF-AEFBFE9EDDC5Q48680598-74780BB5-E9EF-4AE1-80A2-FB382C2A8236Q51163909-37FDBADC-1FF0-429D-A336-A3B5302207DCQ51451420-0C988A54-BC90-4B9D-B25D-E4B26F169626Q51582580-BB77D177-DCA9-438A-96C9-DE5BC5B74F72Q51624222-EB4294E0-6581-4AF9-85C9-3D7EFA3C728AQ55512553-A184E64A-CC0C-4ED1-8436-AE22C9C48B39
P2860
Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prevalence and prognostic valu ...... the GISSI-Heart Failure trial.
@ast
Prevalence and prognostic valu ...... the GISSI-Heart Failure trial.
@en
Prevalence and prognostic valu ...... the GISSI-Heart Failure trial.
@nl
type
label
Prevalence and prognostic valu ...... the GISSI-Heart Failure trial.
@ast
Prevalence and prognostic valu ...... the GISSI-Heart Failure trial.
@en
Prevalence and prognostic valu ...... the GISSI-Heart Failure trial.
@nl
prefLabel
Prevalence and prognostic valu ...... the GISSI-Heart Failure trial.
@ast
Prevalence and prognostic valu ...... the GISSI-Heart Failure trial.
@en
Prevalence and prognostic valu ...... the GISSI-Heart Failure trial.
@nl
P2093
P50
P1476
Prevalence and prognostic valu ...... the GISSI-Heart Failure trial.
@en
P2093
Anna Frisinghelli
Calogero Minneci
Emanuele Carbonieri
GISSI-HF Investigators
Gianni Tognoni
Luciano Moretti
Maria Grazia Rossi
Massimiliano Valisi
Roberto Latini
Roberto Marchioli
P356
10.1161/CIRCHEARTFAILURE.109.881805
P577
2009-10-22T00:00:00Z